1-(5-Isopropyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine

Catalog No.: 
ACZEPO056
CAS No.: 
938459-06-4
Molecular Formula: 
C7H13N3O
Molecular Weight: 
155.20
1-(5-Isopropyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%
1g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-Isopropyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine
IUPAC Name1-(5-isopropyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine
MDL No.MFCD09055314
Molecular FormulaC7H13N3O
Molecular Weight155.20
SMILESCNCC1=NOC(C(C)C)=N1
InChI KeyVQKNAAAIDMNTME-UHFFFAOYSA-N
SynonymDTXSID40650866 | MFCD09055314 | AKOS011622308 | SCHEMBL17790155 | N-Methyl-1-[5-(propan-2-yl)-1,2,4-oxadiazol-3-yl]methanamine | 1-(5-Isopropyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine, AldrichCPR | BS-36412 | N-methyl-1-(5-propan-2-yl-1,2,4-oxadiazol-3-
CAS No.938459-06-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P301+P312+P330

Synthetic Route by SureRoute

1. ACZEPO056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZEPO056 route product structure diagram
    ACZEPO056938459-06-4
Inquiry

2. ACZEPO056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZEPO056 route product structure diagram
    ACZEPO056938459-06-4
Inquiry

3. ACZEPO056 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZEPO056 route product structure diagram
    ACZEPO056938459-06-4
Inquiry

Comments (0)